BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29434332)

  • 1. The p55TNFR-IKK2-Ripk3 axis orchestrates arthritis by regulating death and inflammatory pathways in synovial fibroblasts.
    Armaka M; Ospelt C; Pasparakis M; Kollias G
    Nat Commun; 2018 Feb; 9(1):618. PubMed ID: 29434332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses.
    Victoratos P; Lagnel J; Tzima S; Alimzhanov MB; Rajewsky K; Pasparakis M; Kollias G
    Immunity; 2006 Jan; 24(1):65-77. PubMed ID: 16413924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The caspase-8/RIPK3 signaling axis in antigen presenting cells controls the inflammatory arthritic response.
    Dominguez S; Montgomery AB; Haines GK; Bloomfield CL; Cuda CM
    Arthritis Res Ther; 2017 Oct; 19(1):224. PubMed ID: 28978351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.
    Dondelinger Y; Jouan-Lanhouet S; Divert T; Theatre E; Bertin J; Gough PJ; Giansanti P; Heck AJ; Dejardin E; Vandenabeele P; Bertrand MJ
    Mol Cell; 2015 Oct; 60(1):63-76. PubMed ID: 26344099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
    Dillon CP; Balachandran S
    Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis.
    Marinova-Mutafchieva L; Williams RO; Funa K; Maini RN; Zvaifler NJ
    Arthritis Rheum; 2002 Feb; 46(2):507-13. PubMed ID: 11840454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-146a governs fibroblast activation and joint pathology in arthritis.
    Saferding V; Puchner A; Goncalves-Alves E; Hofmann M; Bonelli M; Brunner JS; Sahin E; Niederreiter B; Hayer S; Kiener HP; Einwallner E; Nehmar R; Carapito R; Georgel P; Koenders MI; Boldin M; Schabbauer G; Kurowska-Stolarska M; Steiner G; Smolen JS; Redlich K; Blüml S
    J Autoimmun; 2017 Aug; 82():74-84. PubMed ID: 28545737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rsk2 controls synovial fibroblast hyperplasia and the course of arthritis.
    Derer A; Böhm C; Grötsch B; Grün JR; Grützkau A; Stock M; Böhm S; Sehnert B; Gaipl U; Schett G; Hueber AJ; David JP
    Ann Rheum Dis; 2016 Feb; 75(2):413-21. PubMed ID: 25414238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
    Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
    Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proinflammatory cytokines IL-1beta and TNF-alpha induce the expression of Synoviolin, an E3 ubiquitin ligase, in mouse synovial fibroblasts via the Erk1/2-ETS1 pathway.
    Gao B; Calhoun K; Fang D
    Arthritis Res Ther; 2006; 8(6):R172. PubMed ID: 17105652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model.
    Khansai M; Phitak T; Klangjorhor J; Udomrak S; Fanhchaksai K; Pothacharoen P; Kongtawelert P
    BMC Complement Altern Med; 2017 Dec; 17(1):532. PubMed ID: 29237438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK1 is not essential for TNFR1-induced activation of NF-kappaB.
    Wong WW; Gentle IE; Nachbur U; Anderton H; Vaux DL; Silke J
    Cell Death Differ; 2010 Mar; 17(3):482-7. PubMed ID: 19927158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation.
    Danks L; Komatsu N; Guerrini MM; Sawa S; Armaka M; Kollias G; Nakashima T; Takayanagi H
    Ann Rheum Dis; 2016 Jun; 75(6):1187-95. PubMed ID: 26025971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone destruction in arthritis.
    Gravallese EM
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
    Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
    Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-Interacting Protein Kinases 1 and 3, and Mixed Lineage Kinase Domain-Like Protein Are Activated by Sublytic Complement and Participate in Complement-Dependent Cytotoxicity.
    Lusthaus M; Mazkereth N; Donin N; Fishelson Z
    Front Immunol; 2018; 9():306. PubMed ID: 29527209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes.
    Aupperle K; Bennett B; Han Z; Boyle D; Manning A; Firestein G
    J Immunol; 2001 Feb; 166(4):2705-11. PubMed ID: 11160335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.